Corticorelin is a synthetic corticotropin-releasing factor analog used to diagnose causes of excessive adrenocorticotropic hormone (ACTH) production. Corticotropin-releasing factor is studied in the treatment of brain cancer.
- Mechanism
- Curator reviewed
Corticotropin-releasing factor is produced by neuroendocrine cells in the paraventricular nucleus of the hypothalamus and is released from neurosecretory terminals of these neurons into the primary capillary plexus of the hypothalamo-hypophyseal portal system. The portal system carries the Corticotropin-releasing hormone(CRH) to the anterior lobe of the pituitary where it stimulates the secretion of corticotropin (ACTH) and other biologically active substances.
- Primary indication
- Investigated for use/treatment in brain cancer and neurologic disorders.Curator reviewed · 7 structured indications
- Also known as
- Corticoliberin human · Corticorelin (human) · Corticotropin releasing hormone human · Corticotropin-releasing factor · Corticotropin-releasing hormone
- Code names
- NEU-3002
Resolves to
What you can answer from here — as of July 03, 2026
Which drugs share a target with Corticorelin, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account